Clinical Trial

Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction

Study acronym: MORE-CSP
Recruiting
View on ClinicalTrials.gov →
Summary
Intraventricular conduction delay alone or in combination with AV conduction delay is associated with a dyssynchronous activation of the ventricles and may result in LV function impairment. Conduction system pacing can restore physiologic ventricular activation in the presence of intraventricular and atrioventricular conduction delays. Patients with intraventricular conduction delay alone or in combination with AV conduction delay who have a permanent pacemaker indication due to intermittent bradycardia and have predominantly intact AV conduction may benefit from continuous CSP.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-10.
Trial Details
NCT Number NCT07585799
Lead Sponsor Óscar Cano Pérez
Conditions Bradycardia
Enrollment 120 participants
Start Date 2025-07-29
Primary Completion 2028-01-15 (estimated)
Study Completion 2029-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-15